PURPOSE: Ionizing radiation is a well-established carcinogen in rodent models and a risk factor associated with human cancer. We developed a mouse model that captures radiation effects on host biology by transplanting unirradiated Trp53-null mammary tissue to sham or irradiated hosts. Gene expression profiles of tumors that arose in irradiated mice are distinct from those that arose in naïve hosts. We asked whether expression metaprofiles could discern radiation-preceded human cancer or be informative in sporadic breast cancers. EXPERIMENTAL DESIGN: Affymetrix microarray gene expression data from 56 Trp53-null mammary tumors were used to define gene profiles and a centroid that discriminates tumors arising in irradiated hosts. These were applied to publicly available human cancer datasets. RESULTS: Host irradiation induces a metaprofile consisting of gene modules representing stem cells, cell motility, macrophages, and autophagy. Human orthologs of the host irradiation metaprofile discriminated between radiation-preceded and sporadic human thyroid cancers. An irradiated host centroid was strongly associated with estrogen receptor-negative breast cancer. When applied to sporadic human breast cancers, the irradiated host metaprofile strongly associated with basal-like and claudin-low breast cancer intrinsic subtypes. Comparing host irradiation in the context of TGF-β levels showed that inflammation was robustly associated with claudin-low tumors. CONCLUSIONS: Detection of radiation-preceded human cancer by the irradiated host metaprofile raises possibilities of assessing human cancer etiology. Moreover, the association of the irradiated host metaprofiles with estrogen receptor-negative status and claudin-low subtype suggests that host processes similar to those induced by radiation underlie sporadic cancers.
PURPOSE:Ionizing radiation is a well-established carcinogen in rodent models and a risk factor associated with humancancer. We developed a mouse model that captures radiation effects on host biology by transplanting unirradiated Trp53-null mammary tissue to sham or irradiated hosts. Gene expression profiles of tumors that arose in irradiated mice are distinct from those that arose in naïve hosts. We asked whether expression metaprofiles could discern radiation-preceded humancancer or be informative in sporadic breast cancers. EXPERIMENTAL DESIGN: Affymetrix microarray gene expression data from 56 Trp53-null mammary tumors were used to define gene profiles and a centroid that discriminates tumors arising in irradiated hosts. These were applied to publicly available humancancer datasets. RESULTS: Host irradiation induces a metaprofile consisting of gene modules representing stem cells, cell motility, macrophages, and autophagy. Human orthologs of the host irradiation metaprofile discriminated between radiation-preceded and sporadic humanthyroid cancers. An irradiated host centroid was strongly associated with estrogen receptor-negative breast cancer. When applied to sporadic humanbreast cancers, the irradiated host metaprofile strongly associated with basal-like and claudin-low breast cancer intrinsic subtypes. Comparing host irradiation in the context of TGF-β levels showed that inflammation was robustly associated with claudin-low tumors. CONCLUSIONS: Detection of radiation-preceded humancancer by the irradiated host metaprofile raises possibilities of assessing humancancer etiology. Moreover, the association of the irradiated host metaprofiles with estrogen receptor-negative status and claudin-low subtype suggests that host processes similar to those induced by radiation underlie sporadic cancers.
Authors: T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale Journal: Proc Natl Acad Sci U S A Date: 2001-09-11 Impact factor: 11.205
Authors: D J Jerry; F S Kittrell; C Kuperwasser; R Laucirica; E S Dickinson; P J Bonilla; J S Butel; D Medina Journal: Oncogene Date: 2000-02-21 Impact factor: 9.867
Authors: C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein Journal: Nature Date: 2000-08-17 Impact factor: 49.962
Authors: Daniel Medina; Frances S Kittrell; Anne Shepard; L Clifton Stephens; Cheng Jiang; Junxuan Lu; D Craig Allred; Maureen McCarthy; Robert L Ullrich Journal: FASEB J Date: 2002-04-10 Impact factor: 5.191
Authors: Erich Huang; Skye H Cheng; Holly Dressman; Jennifer Pittman; Mei Hua Tsou; Cheng Fang Horng; Andrea Bild; Edwin S Iversen; Ming Liao; Chii Ming Chen; Mike West; Joseph R Nevins; Andrew T Huang Journal: Lancet Date: 2003-05-10 Impact factor: 79.321
Authors: Aleix Prat; Joel S Parker; Olga Karginova; Cheng Fan; Chad Livasy; Jason I Herschkowitz; Xiaping He; Charles M Perou Journal: Breast Cancer Res Date: 2010-09-02 Impact factor: 6.466
Authors: Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein Journal: Proc Natl Acad Sci U S A Date: 2003-06-26 Impact factor: 12.779
Authors: Haydeliz Martinez-Ruiz; Irineu Illa-Bochaca; Coral Omene; Douglas Hanniford; Qi Liu; Eva Hernando; Mary Helen Barcellos-Hoff Journal: Sci Signal Date: 2016-12-06 Impact factor: 8.192
Authors: Coral Omene; Lin Ma; Jade Moore; Haoxu Ouyang; Irineu Illa-Bochaca; William Chou; Manan S Patel; Christopher Sebastiano; Sandra Demaria; Jian-Hua Mao; Kubra Karagoz; Michael L Gatza; Mary Helen Barcellos-Hoff Journal: Cancer Immunol Res Date: 2019-12-12 Impact factor: 11.151
Authors: Lin Ma; Alba Gonzalez-Junca; Yufei Zheng; Haoxu Ouyang; Irineu Illa-Bochaca; Kathleen C Horst; Gregor Krings; Yinghao Wang; Ignacio Fernandez-Garcia; William Chou; Mary Helen Barcellos-Hoff Journal: Clin Cancer Res Date: 2021-01-05 Impact factor: 13.801
Authors: Hang Chang; Xu Yang; Jade Moore; Xiao-Ping Liu; Kuang-Yu Jen; Antoine M Snijders; Lin Ma; William Chou; Roberto Corchado-Cobos; Natalia García-Sancha; Marina Mendiburu-Eliçabe; Jesus Pérez-Losada; Mary Helen Barcellos-Hoff; Jian-Hua Mao Journal: Front Oncol Date: 2022-02-11 Impact factor: 6.244